Literature DB >> 12086215

High frame rate myocardial integrated backscatter. Does this change our understanding of this acoustic parameter?

J D'hooge1, B Bijnens, F Jamal, C Pislaru, S Pislaru, J Thoen, P Suetens, F Van de Werf, C Angermann, F E Rademakers, M C Herregods, G R Sutherland.   

Abstract

AIMS: Integrated backscatter (IB) and its cyclic variation (CV) derived from radio-frequency (RF) data have been used as parameters to attempt myocardial tissue characterization. Prior imaging systems used to measure IB and its CV typically acquired data at frame rates of 20-30 Hz and at a resolution of 6-8 bits. If changes in IB levels are in part related to specific short-lived events, occurring within the cardiac cycle, this frame rate and resolution could have been too low to resolve adequately what might be a more complex data set. METHODS AND
RESULTS: To investigate this possibility, we acquired real time two-dimensional (2D) myocardial IQ data (the 'in-phase quadrature' sampled RF data) at high frame rate (> 100 Hz), high dynamic resolution (theoretical 19-bit) and a sector angle of 20 degrees. Several consecutive heart cycles of myocardial data were acquired from individual cardiac walls in five closed chest dogs and 10 healthy, young volunteers at normal heart rates. On the reconstructed RF data regions of interest were indicated, and IB and its CV were calculated. The extracted high frame rate curves showed that the CV of IB is not a smooth sinusoidal-like curve, but is made up of multiple reproducible peaks and troughs with local minima and maxima which are temporally related to active or passive mechanical events, i.e. systolic contraction, early ventricular relaxation and ventricular filling due to atrial contraction.
CONCLUSIONS: This study shows that increasing the rate of real-time RF data acquisition results in a more complex, reproducible IB curve. The resolved maxima and minima in IB levels are related to specific phases of the myocardial contraction. Furthermore, spectral analysis showed that IB curves acquired at normal heart rates contain information up to 40 Hz. Hence, cardiac imaging data sets used to analyse regional myocardial function obtained at frequencies lower than 80 frames per second can contain aliased information.

Entities:  

Mesh:

Year:  2000        PMID: 12086215     DOI: 10.1053/euje.2000.0004

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  5 in total

1.  Ultrasonic assessment of myocardial microstructure.

Authors:  Pranoti Hiremath; Michael Bauer; Hui-Wen Cheng; Kazumasa Unno; Ronglih Liao; Susan Cheng
Journal:  J Vis Exp       Date:  2014-01-14       Impact factor: 1.355

2.  Feasibility and Reproducibility of Two-Dimensional Wall Motion Tracking (WMT) in Fetal Echocardiography.

Authors:  Christian Enzensberger; Friederike Achterberg; Jan Degenhardt; Aline Wolter; Oliver Graupner; Johannes Herrmann; Roland Axt-Fliedner
Journal:  Ultrasound Int Open       Date:  2017-02

3.  Evolution of strain and strain rate values throughout gestation in healthy fetuses.

Authors:  Marcos Clavero Adell; Ariadna Ayerza Casas; Lorenzo Jiménez Montañés; Daniel Palanca Arias; Marta López Ramón; José-Tomás Alcalá Nalvaiz; Pilar Samper Villagrasa
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-29       Impact factor: 2.357

4.  Use of myocardial backscatter as a quantitative tool for dobutamine echocardiography: feasibility, response to ischemia and accuracy compared with coronary angiography.

Authors:  Jared Dart; Satoshi Yuda; Peter Cain; Colin Case; Thomas H Marwick
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

5.  Echocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats.

Authors:  Bram Roosens; Gezim Bala; Kris Gillis; Isabel Remory; Steven Droogmans; Joan Somja; Eléonore Delvenne; Joeri De Nayer; Johan Schiettecatte; Philippe Delvenne; Patrizio Lancellotti; Guy Van Camp; Bernard Cosyns
Journal:  Cardiovasc Ultrasound       Date:  2013-01-26       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.